Maslinic acid suppresses osteoclastogene
β
Chenghai Li; Zhengfeng Yang; Zhenxi Li; Yu Ma; Lipeng Zhang; Chunbing Zheng; Wen
π
Article
π
2011
π
American Society for Bone and Mineral Research
π
English
β 714 KB
## Abstract Activation of NFβΞΊB and MAPK/activator protein 1 (APβ1) signaling pathways by receptor activator NFβΞΊB ligand (RANKL) is essential for osteoclast activity. Targeting NFβΞΊB and MAPK/APβ1 signaling to modulate osteoclast activity has been a promising strategy for osteoclastβrelated diseas